SOLFRIZZI, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 16.550
EU - Europa 2.827
AS - Asia 1.545
OC - Oceania 32
AF - Africa 10
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.969
Nazione #
US - Stati Uniti d'America 16.526
CN - Cina 958
SE - Svezia 682
UA - Ucraina 481
DE - Germania 408
SG - Singapore 408
IT - Italia 397
FI - Finlandia 287
GB - Regno Unito 176
FR - Francia 131
IE - Irlanda 61
NL - Olanda 57
VN - Vietnam 56
IN - India 51
RU - Federazione Russa 47
BE - Belgio 33
AU - Australia 29
CA - Canada 24
RO - Romania 19
HK - Hong Kong 17
IR - Iran 12
GR - Grecia 8
JP - Giappone 8
KR - Corea 6
LT - Lituania 6
CZ - Repubblica Ceca 5
ES - Italia 5
TH - Thailandia 5
AL - Albania 4
PL - Polonia 4
ZA - Sudafrica 4
AT - Austria 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
TR - Turchia 2
TW - Taiwan 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BR - Brasile 1
HR - Croazia 1
LK - Sri Lanka 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 20.969
Città #
Fairfield 2.576
Woodbridge 2.046
Houston 1.374
Chandler 1.258
Ashburn 1.229
Jacksonville 1.117
Seattle 1.102
Ann Arbor 889
Cambridge 858
Wilmington 782
Nyköping 552
Singapore 312
Roxbury 296
Lawrence 295
Nanjing 288
Des Moines 205
Beijing 198
Boardman 159
New York 117
Princeton 112
Bari 102
San Diego 95
Santa Clara 69
Nanchang 68
Brooklyn 65
Shenyang 62
Inglewood 61
Dublin 59
Hebei 56
Dearborn 55
Jiaxing 49
Los Angeles 45
Paris 41
Strasbourg 39
Dong Ket 38
Ostuni 36
Changsha 35
London 35
Tianjin 35
Pune 34
Brussels 33
Ruvo Di Puglia 32
Washington 27
Redwood City 25
Helsinki 24
Munich 24
Norwalk 18
San Mateo 18
Chanh Hiep 16
Toronto 16
Guangzhou 15
Melbourne 15
Auburn Hills 13
Falls Church 13
Leawood 13
Redmond 13
San Francisco 13
Shanghai 13
Groningen 12
Scottsdale 12
Taranto 12
San Jose 11
Augusta 10
Ardabil 9
Hong Kong 9
Las Vegas 9
Henderson 8
Kilburn 8
Milan 8
Sydney 8
Hefei 7
Ningbo 7
Rome 7
Foggia 6
San Genesio Ed Uniti 6
Wuhan 6
Zhengzhou 6
Acton 5
Bangkok 5
Canberra 5
Central 5
Monmouth Junction 5
Prescot 5
Amsterdam 4
Chiswick 4
Detroit 4
Haikou 4
Moscow 4
New Bedfont 4
Palermo 4
Phoenix 4
Tübingen 4
West Palm Beach 4
Xian 4
Buffalo 3
Chicago 3
Chongqing 3
Corfu 3
Cutrofiano 3
Florence 3
Totale 17.438
Nome #
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 263
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 233
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 171
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 169
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 160
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 146
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 141
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 134
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 134
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 131
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 130
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 129
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 117
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 115
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 114
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 114
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 112
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 112
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 110
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 107
Vascular risk factors, alcohol intake, and cognitive decline 106
Age-related changes of serum N-acetyl-aspartate in healthy controls. 106
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 106
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 105
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 105
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 105
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 105
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 105
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome 104
Epidemiology of age related hearing loss: A review 103
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 102
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 102
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 102
Aluminium in the diet, cognitive decline and dementia. 101
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 101
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia 100
All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a) 100
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 100
Cognitive frailty: Predementia syndrome and vascular risk factors 99
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 99
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 99
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 98
S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease 97
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 96
Cognitive frailty: a potential target for secondary prevention of dementia 96
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 96
Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: A systematic review and meta-analysis of individual participant data 95
Mediterranean diet and cognitive decline 94
Dietary unsaturated fatty acids and risk of mild cognitive impairment 93
Assessment of sense of taste in Italian centenarians 93
Analysis of some aspects of learning and memorization processes in an adult population. 93
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 93
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys 93
Metabolic syndrome, mild cognitive impairment, and dementia 92
A rehabilitation program for mild memory impairments. 92
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 92
Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment 92
Nutritional factors, cognitive decline, and dementia 91
Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians 91
Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging 90
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 90
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants 90
Dietary patterns, foods, and food groups: Relation to late-life cognitive disorders 90
Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia 89
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease 89
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging 89
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries 89
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 88
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 88
Current epidemiology of mild cognitive impairment and other predementia syndromes2 87
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease 87
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 87
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 87
Impact of aging on the relationships between impairment of "Orientation" and "Recall" items of MMSE and mild to moderate mood disorders. 86
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 86
Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease [7] 86
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 86
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 85
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 85
Alcohol consumption, mild cognitive impairment, and progression to dementia 85
Molecular determinants of human longevity 83
Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe 83
N-3 polyunsaturated fatty acids and statins in heart failure 83
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? 83
Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects 83
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 83
Vascular risk and genetics of sporadic late-onset Alzheimer's disease 82
Vascular risk factors, incidence of MCI, and rates of progression to dementia 82
Mediterranean diet in predementia and dementia syndromes 82
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 82
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia 82
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 81
Unsaturated fatty acids intake and all-causes mortality : a 8.5-year follow-up of the italian Longitudinal Study on Aging 81
Alcohol Consumption in Predementia and Dementia Syndromes 81
Moderate alcohol consumption, apolipoprotein E, and neuroprotection 81
Plant-based nutraceutical interventions against cognitive impairment and dementia: Meta-analytic evidence of efficacy of a standardized Gingko biloba extract 81
Monounsaturated fatty acids and neuroprotection. The results of a study of cognitive decline in old age. Is there a case for this treatment in multiple sclerosis? 80
Lipoproteins, vascular-related genetic factors, and human longevity 80
Nutrition, frailty, and Alzheimer's disease. 80
Progression to dementia in probable and possible mild cognitive impairment 80
Totale 10.156
Categoria #
all - tutte 81.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.935 0 0 0 0 679 413 616 563 739 284 498 143
2020/20213.557 308 224 293 453 416 275 283 202 280 456 189 178
2021/20221.840 64 165 12 67 101 184 71 88 152 135 320 481
2022/20233.167 510 300 215 305 379 405 34 369 492 20 79 59
2023/20241.153 106 192 75 73 94 248 55 65 38 55 29 123
2024/2025847 92 79 449 174 53 0 0 0 0 0 0 0
Totale 21.680